Professor of Radiation Oncology, Tufts University
Radiation Oncology
Dr. David E. Wazer, MD
|
|
Give Review
Doctor David E. Wazer, MD is an expert in the field of Radiation Oncology. He went to medical school at NYU School of Medicine. He over the years received 4 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Redbook Magazine: Top Breast Cancer Doctors" and "Super Doctor". David Wazer is also published. He has 76 publications published. The lastest publication: "The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review.' He accepts Medicare.
Publications
- Brachytherapy: where has it gone?
- A flawed study should not define a new standard of care.
- Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 2--TARGIT.
- Local recurrence and survival following stereotactic radiosurgery for brain metastases from small cell lung cancer.
- Bending the cost curve: a unique collaboration between radiation oncologists and blue cross blue shield of massachusetts to optimize the use of advanced technology.
- Intraoperative Radiation Therapy: A Critical Analysis of the ELIOT and TARGIT Trials. Part 1-ELIOT.
- The rationale, technique, and feasibility of partial breast irradiation using noninvasive image-guided breast brachytherapy.
- Radiotherapy for breast cancer, the TARGIT-A trial.
- Breast Boost Using Noninvasive Image-Guided Breast Brachytherapy vs. External Beam: A 2:1 Matched-Pair Analysis.
- Patterns of care of radiation therapy in patients with stage IV rectal cancer: A Surveillance, Epidemiology, and End Results analysis of patients from 2004 to 2009.
- When Retrospective Comparative Effectiveness Research Hinders Science and Patient-Centered Care.
- Should a Woman Age 70 to 80 Years Receive Radiation After Breast-Conserving Surgery?
- The American Brachytherapy Society consensus statement for accelerated partial breast irradiation.
- Utilization of proton therapy: evidence-based, market-driven, or something in-between?
- Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Socie...
- The Effect of Dose-Volume Parameters and Interfraction Interval on Cosmetic Outcome and Toxicity After 3-Dimensional Conformal Accelerated Partial Breast Irradiation.
- Measuring the Value of Radiotherapy in Older Women With Breast Cancer.
- A Multi-Institutional Study of Feasibility, Implementation, and Early Clinical Results with Noninvasive Breast Brachytherapy for Tumor Bed Boost.
- A comparison of the biological effective dose of 50-kV electronic brachytherapy with (192)Ir high-dose-rate brachytherapy for vaginal cuff irradiation.
- Prevalence of Poor Cardiac Anatomy in Carcinoma of the Breast Treated With Whole-breast Radiotherapy: Reconciling Modern Cardiac Dosimetry With Cardiac Mortality Data.
- A comparison of brachytherapy techniques for partial breast irradiation.
- Dose modeling of noninvasive image-guided breast brachytherapy in comparison to electron beam boost and three-dimensional conformal accelerated partial breast irradiat...
- Exploring the potential of mixed-source brachytherapy for the treatment of cervical cancer using high-dose rate 192Ir and/or 50 kV electronic sources.
- The use of adjuvant high-dose-rate breast brachytherapy in patients with collagen vascular disease: a collaborative experience.
- A novel ytterbium-169 brachytherapy source and delivery system for use in conjunction with minimally invasive wedge resection of early-stage lung cancer.
- Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation.
- Evaluation of potential proton therapy utilization in a market-based environment.
- Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy.
- Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator.
- Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation.
- Dosimetric characterization of round HDR 192Ir accuboost applicators for breast brachytherapy.
- Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
- Planning the breast boost: comparison of three techniques and evolution of tumor bed during treatment.
- Point: Brachytherapy for accelerated partial breast irradiation.
- Intensity-modulated radiotherapy of the prostate after cryotherapy: initial experience.
- A dosimetric comparison of Xoft Axxent Electronic Brachytherapy and iridium-192 high-dose-rate brachytherapy in the treatment of endometrial cancer.
- Management of the axilla after the finding of a positive sentinel lymph node: a proposal for an evidence-based risk-adapted algorithm.
- Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results.
- An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.
- Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
- Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer.
- The notch regulator MAML1 interacts with p53 and functions as a coactivator.
- Patient selection for NSABP B-39/RTOG 0413: have we posed the right questions in the right way?
- Severe acute toxicity from whole breast radiotherapy in the setting of collagen vascular disease.
- The HBP1 transcriptional repressor participates in RAS-induced premature senescence.
- Dose-modeling study to compare external beam techniques from protocol NSABP B-39/RTOG 0413 for patients with highly unfavorable cardiac anatomy.
- Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: incidence, pathologic anatomy, and contributing factors.
- Tumor bed boost omission after negative re-excision in breast-conservation treatment.
- Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repres...
- Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachyt...
- Accelerated partial breast irradiation: current modalities and investigations.
- Centrobin: a novel daughter centriole-associated protein that is required for centriole duplication.
- A radiobiological model for the relative biological effectiveness of high-dose-rate 252Cf brachytherapy.
- MammoSite excision volume as a predictor for residual disease.
- A remembrance of Rupert K. A. Schmidt-Ullrich, M.D.
- The MammoSite balloon brachytherapy catheter for accelerated partial breast irradiation.
- Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivation.
- MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis.
- Analysis of dose conformity and normal-tissue sparing using two different IMRT prescription methodologies for irregularly shaped CNS lesions irradiated with the Beak a...
- Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery.
- Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results.
- Determination of the 4 mm Gamma Knife helmet relative output factor using a variety of detectors.
- ErbB2 degradation mediated by the co-chaperone protein CHIP.
- The high-risk human papillomavirus type 16 E6 counters the GAP function of E6TP1 toward small Rap G proteins.
- Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy.
- Inconsistency, perspective, double talk, and false virtue.
- Molecular biology and genetics of breast cancer development: a clinical perspective.
- The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.
- Implementation and utility of a daily ultrasound-based localization system with intensity-modulated radiotherapy for prostate cancer.
- Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.
- Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer.
- Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
- The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.
- The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review.
- Regional Nodal Irradiation: Examining the Clinical Implications of Randomized Trials.
Schools
New York University School Of Medicine
Roger Williams Genl Hospital
Tufts New England Med Center
New York University Med Center
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Redbook Magazine: Top Breast Cancer Doctors
- Super Doctor
Education
-
Tufts Medical Center -
Brown University Affiliated Hospitals -
NYU School of Medicine
Hospital
-
Tufts Medical Center -
Rhode Island Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1821053653 |
| Last Name Of The Provider | WAZER |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Mohamedyakub A. Puthawala, MB
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Casey J. Maks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kara L. Leonard, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nicklas B. Oldenburg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Scott A. Triedman, MD
This Doctor is OpenDoctor Recommended.
|